These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The radiometal makes a difference. Synthesis and preliminary characterisation of DOTA-minigastrin analogue complexes with Ga, Lu and Y. Maurin M; Garnuszek P; Baran P; Pawlak D; Mikołajczak R Nucl Med Rev Cent East Eur; 2015; 18(2):51-5. PubMed ID: 26315862 [TBL] [Abstract][Full Text] [Related]
25. Semi-automated 86Y purification using a three-column system. Park LS; Szajek LP; Wong KJ; Plascjak PS; Garmestani K; Googins S; Eckelman WC; Carrasquillo JA; Paik CH Nucl Med Biol; 2004 Feb; 31(2):297-301. PubMed ID: 15013497 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the stability of Y-90-, Lu-177- and Ga-68- labeled human serum albumin microspheres (DOTA-HSAM). Wunderlich G; Schiller E; Bergmann R; Pietzsch HJ Nucl Med Biol; 2010 Nov; 37(8):861-7. PubMed ID: 21055615 [TBL] [Abstract][Full Text] [Related]
27. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes. Sosabowski JK; Mather SJ Nat Protoc; 2006; 1(2):972-6. PubMed ID: 17406332 [TBL] [Abstract][Full Text] [Related]
28. Octreotide and octreotate derivatives radiolabeled with yttrium: pharmacokinetics in rats. Laznicek M; Laznickova A; Mäcke HR; Eisenwiener K; Reubi JC; Wenger S Cancer Biother Radiopharm; 2002 Oct; 17(5):527-33. PubMed ID: 12470422 [TBL] [Abstract][Full Text] [Related]
29. Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity. Mueller D; Klette I; Baum RP; Gottschaldt M; Schultz MK; Breeman WA Bioconjug Chem; 2012 Aug; 23(8):1712-7. PubMed ID: 22755505 [TBL] [Abstract][Full Text] [Related]
30. Radiolabeling of PAMAM dendrimers conjugated to a pyridine-N-oxide DOTA analog with ¹¹¹In: Optimization of reaction conditions and biodistribution. Biricová V; Lázničková A; Lázníček M; Polášek M; Hermann P J Pharm Biomed Anal; 2011 Nov; 56(3):505-12. PubMed ID: 21757312 [TBL] [Abstract][Full Text] [Related]
31. Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals. Lewis MR; Reichert DE; Laforest R; Margenau WH; Shefer RE; Klinkowstein RE; Hughey BJ; Welch MJ Nucl Med Biol; 2002 Aug; 29(6):701-6. PubMed ID: 12234596 [TBL] [Abstract][Full Text] [Related]
32. Formulation and purification of therapeutic dose of Chakravarty R; Chakraborty S; Dash A Appl Radiat Isot; 2017 Mar; 121():1-5. PubMed ID: 28012419 [TBL] [Abstract][Full Text] [Related]
34. Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method. Li M; Meares CF; Zhong GR; Miers L; Xiong CY; DeNardo SJ Bioconjug Chem; 1994; 5(2):101-4. PubMed ID: 8031871 [TBL] [Abstract][Full Text] [Related]
35. Semiautomated labelling and fractionation of yttrium-90 and lutetium-177 somatostatin analogues using disposable syringes and vials. Asti M; Atti G; Iori M; Farioli D; Filice A; Versari A Nucl Med Commun; 2012 Nov; 33(11):1144-52. PubMed ID: 22889932 [TBL] [Abstract][Full Text] [Related]
36. Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases. Ogawa K; Kawashima H; Shiba K; Washiyama K; Yoshimoto M; Kiyono Y; Ueda M; Mori H; Saji H Nucl Med Biol; 2009 Feb; 36(2):129-35. PubMed ID: 19217524 [TBL] [Abstract][Full Text] [Related]